We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Class Action

Class Action Law360 provides breaking news and analysis on class actions and multidistrict litigation. Coverage includes developments in multiparty litigation in federal and state courts, as well as policy issues and court rulings that affect class action procedure.



Sign up for a 7-day FREE trial today!



Latest News in Class Action

  • January 23, 2019

    Difficult Questions On Class Action Removal At High Court

    Based on the justices' questioning during oral arguments in Home Depot v. Jackson, the U.S. Supreme Court is grappling with the interplay of precedent, statutory text and policy issues concerning the Class Action Fairness Act, say Ryan Tosi and Scott Ofrias of K&L Gates LLP.

  • January 22, 2019

    Archer Daniels Escapes Bulk Of Deadly Horse Feed Suit

    Archer Daniels Midland Co. on Tuesday dodged much of a proposed class action brought by two horse owners who alleged contaminated feed products harmed their animals, when an Illinois federal judge said most of the owners' claims don't have a legal foundation.

  • January 22, 2019

    Casino Fights Dealer's Quick Win Bid In FLSA Tip Pool Suit

    Penn National Gaming Inc. pushed back Tuesday in West Virginia federal court against a dealer’s bid for a quick win in her proposed class action challenging a company casino’s tip pool policy, saying the casino did not improperly divert tip money when paying dealers out on leave.

  • January 22, 2019

    Rakoff Tosses Suit Against L'Oreal, Cites Risk Of 'Ambush'

    U.S. District Judge Jed Rakoff on Tuesday dismissed a class action accusing L'Oreal of deceptively marketing a black women’s hair relaxer as scalp-protecting but that instead caused burns and hair loss, blasting a tardy damages report as inadequate and "trial by ambush."

  • January 22, 2019

    Direct Buyers Fight GSK, Teva's Bid To Stay Lamictal Suit

    Drug wholesalers urged a New Jersey federal court Monday to nix a bid from GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. to pause an antitrust suit over the availability of generic alternatives to epilepsy drug Lamictal while the companies seek Third Circuit review of the direct buyers’ class certification.

See more Class Action news

Class action

Areas of Coverage

  • LITIGATION
  • Putative class action complaints
  • Class certification and decertification motions and orders
  • Certification appeals
  • Class settlements
  • Case rulings and appeals
  • Collective actions
  • Multidistrict litigation
  • Shareholder actions
  • Disputes over counsel and attorneys fees in multiparty litigation
  • Expert witness disputes
  • POLICY & REGULATION
  • Federal and state regulation and legislation affecting class action procedure
  • PROFILES
  • Personnel moves
  • Profiles of class action practices

Readership

  • Class action lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals